These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22250763)

  • 21. Fetal phallus 'erection' interfering with the sonographic determination of fetal gender in the first trimester.
    Pedreira DA; Yamasaki A; Czeresnia CE
    Ultrasound Obstet Gynecol; 2001 Oct; 18(4):402-4. PubMed ID: 11779004
    [No Abstract]   [Full Text] [Related]  

  • 22. Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities.
    Ritchie K; Bradbury I; Slattery J; Wright D; Iqbal K; Penney G
    BJOG; 2005 Jul; 112(7):866-74. PubMed ID: 15957985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sonographic biometrical range of external genitalia differentiation in the first trimester of pregnancy: analysis of 2593 cases.
    Mazza V; Di Monte I; Pati M; Contu G; Ottolenghi C; Forabosco A; Volpe A
    Prenat Diagn; 2004 Sep; 24(9):677-84. PubMed ID: 15386456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester screening: economic implications.
    Macones GA; Odibo A
    Semin Perinatol; 2005 Aug; 29(4):263-6. PubMed ID: 16104679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of crosstrimester test in selecting high-risk pregnant women to undergo invasive prenatal diagnosis.
    Guanciali-Franchi P; Iezzi I; Matarrelli B; Morizio E; Calabrese G; Palka G
    Prenat Diagn; 2010 Aug; 30(8):795-6. PubMed ID: 20575153
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.
    Odibo AO; Ghidini A
    Prenat Diagn; 2014 Jun; 34(6):511-7. PubMed ID: 24436177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology.
    Wyatt P
    Prenat Diagn; 2007 Feb; 27(2):186-7. PubMed ID: 17266162
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-invasive prenatal testing: more questions than answers.
    Yagel S
    Ultrasound Obstet Gynecol; 2013 Oct; 42(4):369-72. PubMed ID: 23417886
    [No Abstract]   [Full Text] [Related]  

  • 29. Sonographic determination of fetal gender.
    Scholly TA; Sutphen JH; Hitchcock DA; Mackey SC; Langstaff LM
    AJR Am J Roentgenol; 1980 Dec; 135(6):1161-5. PubMed ID: 6779520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive fetal sex determination by maternal plasma sequencing and application in X-linked disorder counseling.
    Pan X; Zhang C; Li X; Chen S; Ge H; Zhang Y; Chen F; Jiang H; Jiang F; Zhang H; Wang W; Zhang X
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1829-33. PubMed ID: 24444365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound determination of foetal gender: accuracy and social implications.
    Nzeh DA
    East Afr Med J; 1996 Apr; 73(4):225-7. PubMed ID: 8706603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive or non-invasive prenatal genetic diagnosis?
    Monni G; Zoppi MA; Iuculano A; Piras A; Arras M
    J Perinat Med; 2014 Sep; 42(5):545-8. PubMed ID: 25205707
    [No Abstract]   [Full Text] [Related]  

  • 33. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prenetal diagnosis: analysis of combined screening for first trimester].
    Escudero Fernandez M
    An R Acad Nac Med (Madr); 2006; 123(3):597-612; discussion 612-6. PubMed ID: 17451100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal screening for birth defects: an update.
    Morris K
    Mo Med; 2004; 101(2):121-4. PubMed ID: 15119110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ; Rudnicka AR; Bestwick JP
    Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal gender screening by ultrasound at 11 to 13(+6) weeks.
    Hsiao CH; Wang HC; Hsieh CF; Hsu JJ
    Acta Obstet Gynecol Scand; 2008; 87(1):8-13. PubMed ID: 17851807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal gender determination using ultrasound scanning.
    Sirisena J; Fernando S
    Ceylon Med J; 1997 Mar; 42(1):21-3. PubMed ID: 9164026
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province.
    Metcalfe A; Currie G; Johnson JA; Bernier F; Lix LM; Lyon AW; Tough SC
    Prenat Diagn; 2013 May; 33(5):429-35. PubMed ID: 23519599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination.
    Hromadnikova I; Houbova B; Hridelova D; Voslarova S; Kofer J; Komrska V; Habart D
    Prenat Diagn; 2003 Mar; 23(3):235-8. PubMed ID: 12627426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.